Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Amaral FMR"'
Autor:
Nicosia L; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK., Spencer GJ; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK., Brooks N; CellCentric Ltd., Cambridge CB10 1XL, UK., Amaral FMR; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK., Basma NJ; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK., Chadwick JA; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK., Revell B; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK., Wingelhofer B; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK., Maiques-Diaz A; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK., Sinclair O; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK., Camera F; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK., Ciceri F; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK., Wiseman DH; Epigenetics of Haematopoiesis Group, The University of Manchester, Manchester M20 4BX, UK., Pegg N; CellCentric Ltd., Cambridge CB10 1XL, UK., West W; CellCentric Ltd., Cambridge CB10 1XL, UK., Knurowski T; CellCentric Ltd., Cambridge CB10 1XL, UK., Frese K; CellCentric Ltd., Cambridge CB10 1XL, UK., Clegg K; CellCentric Ltd., Cambridge CB10 1XL, UK., Campbell VL; Western General Hospital, Edinburgh EH4 2XU, UK., Cavet J; The Christie NHS Foundation Trust, Manchester M20 4BX, UK., Copland M; Paul O'Gorman Leukaemia Research Centre, University of Glasgow, Glasgow G12 0YN, UK., Searle E; The Christie NHS Foundation Trust, Manchester M20 4BX, UK., Somervaille TCP; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK; The Christie NHS Foundation Trust, Manchester M20 4BX, UK. Electronic address: tim.somervaille@cruk.manchester.ac.uk.
Publikováno v:
Cancer cell [Cancer Cell] 2023 Dec 11; Vol. 41 (12), pp. 2136-2153.e13. Date of Electronic Publication: 2023 Nov 22.
Autor:
Wang YH; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.; Epigenetics Haematopoiesis Laboratory, Division of Cancer Sciences, The University of Manchester, Manchester, UK., Lin CC; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan. jake9665@gmail.com.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan. jake9665@gmail.com., Gurashi K; Epigenetics Haematopoiesis Laboratory, Division of Cancer Sciences, The University of Manchester, Manchester, UK., Wingelhofer B; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, Manchester, UK., Amaral FMR; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, Manchester, UK., Yao CY; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan., Hsieh HT; Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan., Liu MC; Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan., Hou HA; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan., Chou WC; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan., Batta K; Epigenetics Haematopoiesis Laboratory, Division of Cancer Sciences, The University of Manchester, Manchester, UK., Wiseman DH; Epigenetics Haematopoiesis Laboratory, Division of Cancer Sciences, The University of Manchester, Manchester, UK., Tien HF; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan. hftien@ntu.edu.tw.; Department of Internal Medicine, Fra-Eastern Memorial Hospital, New Taipei City, Taiwan. hftien@ntu.edu.tw.
Publikováno v:
Leukemia [Leukemia] 2023 Dec; Vol. 37 (12), pp. 2507-2511. Date of Electronic Publication: 2023 Nov 02.
Autor:
Ginn L; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, United Kingdom., Maltas J; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, United Kingdom., Baker MJ; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, United Kingdom., Chaturvedi A; The Christie National Health Service Foundation Trust, Manchester M20 4BX, United Kingdom., Wilson L; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, United Kingdom., Guilbert R; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, United Kingdom., Amaral FMR; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, United Kingdom., Priest L; The Christie National Health Service Foundation Trust, Manchester M20 4BX, United Kingdom., Mole H; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester M13 9PT, United Kingdom., Blackhall F; The Christie National Health Service Foundation Trust, Manchester M20 4BX, United Kingdom.; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester M13 9PT, United Kingdom., Diamantopoulou Z; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, United Kingdom., Somervaille TCP; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, United Kingdom., Hurlstone A; Division of Immunology, Infection and Respiratory Medicine, School of Biological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester M13 9PT, United Kingdom., Malliri A; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, United Kingdom.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2023 Oct 03; Vol. 120 (40), pp. e2300489120. Date of Electronic Publication: 2023 Sep 25.
Autor:
Camera F; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, The Oglesby Cancer Research Centre Building, 555 Wilmslow Road, M20 4GJ Manchester, UK., Romero-Camarero I; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, The Oglesby Cancer Research Centre Building, 555 Wilmslow Road, M20 4GJ Manchester, UK., Revell BH; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, The Oglesby Cancer Research Centre Building, 555 Wilmslow Road, M20 4GJ Manchester, UK., Amaral FMR; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, The Oglesby Cancer Research Centre Building, 555 Wilmslow Road, M20 4GJ Manchester, UK., Sinclair OJ; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, The Oglesby Cancer Research Centre Building, 555 Wilmslow Road, M20 4GJ Manchester, UK., Simeoni F; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, The Oglesby Cancer Research Centre Building, 555 Wilmslow Road, M20 4GJ Manchester, UK., Wiseman DH; Epigenetics of Haematopoiesis Group, Oglesby Cancer Research Building, The University of Manchester, M20 4GJ Manchester, UK., Stojic L; Centre for Cancer Cell and Molecular Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, EC1M 6BQ London, UK., Somervaille TCP; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, The Oglesby Cancer Research Centre Building, 555 Wilmslow Road, M20 4GJ Manchester, UK.
Publikováno v:
IScience [iScience] 2023 Jul 11; Vol. 26 (8), pp. 107319. Date of Electronic Publication: 2023 Jul 11 (Print Publication: 2023).
Autor:
Wang YH; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom.; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, Manchester, United Kingdom., Lin CC; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan., Yao CY; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan., Amaral FMR; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, Manchester, United Kingdom., Yu SC; Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan., Kao CJ; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Shih PT; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Hou HA; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Chou WC; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan., Tien HF; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
Publikováno v:
Blood advances [Blood Adv] 2023 Jun 13; Vol. 7 (11), pp. 2528-2533.
Autor:
Pearson S; Stem Cell and Leukaemia Proteomics Laboratory, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom., Blance R; Stem Cell and Leukaemia Proteomics Laboratory, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom., Yan F; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.; Cancer Research UK Beatson Institute, Glasgow, United Kingdom., Hsieh YC; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.; Cancer Research UK Beatson Institute, Glasgow, United Kingdom., Geary B; Stoller Biomarker Discovery Centre, University of Manchester, Manchester, United Kingdom., Amaral FMR; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, Manchester, United Kingdom., Somervaille TCP; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, Manchester, United Kingdom., Kirschner K; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.; Cancer Research UK Beatson Institute, Glasgow, United Kingdom., Whetton AD; Stem Cell and Leukaemia Proteomics Laboratory, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom., Pierce A; Stem Cell and Leukaemia Proteomics Laboratory, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
Publikováno v:
PloS one [PLoS One] 2023 May 30; Vol. 18 (5), pp. e0286412. Date of Electronic Publication: 2023 May 30 (Print Publication: 2023).
Autor:
Wang YH; Division of Cancer Sciences, The University of Manchester, Manchester, UK.; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, Manchester, UK., Yao CY; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan., Lin CC; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan., Gurashi K; Division of Cancer Sciences, The University of Manchester, Manchester, UK., Amaral FMR; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, Manchester, UK., Bossenbroek H; Division of Cancer Sciences, The University of Manchester, Manchester, UK., Jerez A; Haematology Department, Hospital Morales Meseguer, Murcia, Spain., Somervaille TCP; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, Manchester, UK., Binder M; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Patnaik MM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Hou HA; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan., Chou WC; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan., Batta K; Division of Cancer Sciences, The University of Manchester, Manchester, UK., Wiseman DH; Division of Cancer Sciences, The University of Manchester, Manchester, UK., Tien HF; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, Fra-Eastern Memorial Hospital, New Taipei City, Taiwan.
Publikováno v:
British journal of haematology [Br J Haematol] 2023 Apr; Vol. 201 (2), pp. 302-307. Date of Electronic Publication: 2023 Feb 06.
Autor:
Maiques-Diaz A; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester Cancer Research Centre Building, 555 Wilmslow Road, Manchester, M20 4GJ, UK., Nicosia L; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester Cancer Research Centre Building, 555 Wilmslow Road, Manchester, M20 4GJ, UK., Basma NJ; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester Cancer Research Centre Building, 555 Wilmslow Road, Manchester, M20 4GJ, UK., Romero-Camarero I; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester Cancer Research Centre Building, 555 Wilmslow Road, Manchester, M20 4GJ, UK., Camera F; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester Cancer Research Centre Building, 555 Wilmslow Road, Manchester, M20 4GJ, UK., Spencer GJ; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester Cancer Research Centre Building, 555 Wilmslow Road, Manchester, M20 4GJ, UK., Amaral FMR; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester Cancer Research Centre Building, 555 Wilmslow Road, Manchester, M20 4GJ, UK., Simeoni F; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester Cancer Research Centre Building, 555 Wilmslow Road, Manchester, M20 4GJ, UK., Wingelhofer B; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester Cancer Research Centre Building, 555 Wilmslow Road, Manchester, M20 4GJ, UK., Williamson AJK; Stem Cell and Leukaemia Proteomics Laboratory, Manchester Academic Health Science Centre, The University of Manchester, Wolfson Molecular Imaging Centre, 27 Palatine Road, Manchester, M20 3LJ, UK., Pierce A; Stem Cell and Leukaemia Proteomics Laboratory, Manchester Academic Health Science Centre, The University of Manchester, Wolfson Molecular Imaging Centre, 27 Palatine Road, Manchester, M20 3LJ, UK.; School of Medical and Health Sciences, College of Human Sciences, Fron Heulog Bangor University, Bangor, LL57 2TH, UK., Whetton AD; Stem Cell and Leukaemia Proteomics Laboratory, Manchester Academic Health Science Centre, The University of Manchester, Wolfson Molecular Imaging Centre, 27 Palatine Road, Manchester, M20 3LJ, UK.; School of Veterinary Medicine and School of Biosciences and Medicine, University of Surrey, VSM Building, University of Surrey, Guildford, GU2 7AL, UK., Somervaille TCP; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester Cancer Research Centre Building, 555 Wilmslow Road, Manchester, M20 4GJ, UK. tim.somervaille@cruk.manchester.ac.uk.
Publikováno v:
Oncogene [Oncogene] 2022 Oct; Vol. 41 (44), pp. 4841-4854. Date of Electronic Publication: 2022 Sep 28.
Autor:
Williams MS; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, Oglesby Cancer Research Building, The University of Manchester, 555 Wilmslow Road, Manchester, M20 4GJ, UK. mark.williams-4@manchester.ac.uk., Basma NJ; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, Oglesby Cancer Research Building, The University of Manchester, 555 Wilmslow Road, Manchester, M20 4GJ, UK., Amaral FMR; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, Oglesby Cancer Research Building, The University of Manchester, 555 Wilmslow Road, Manchester, M20 4GJ, UK., Wiseman DH; Epigenetics of Haematopoiesis Group, Oglesby Cancer Research Building, The University of Manchester, Manchester, M20 4GJ, UK., Somervaille TCP; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, Oglesby Cancer Research Building, The University of Manchester, 555 Wilmslow Road, Manchester, M20 4GJ, UK. tim.somervaille@cruk.manchester.ac.uk.
Publikováno v:
BMC cancer [BMC Cancer] 2021 Oct 28; Vol. 21 (1), pp. 1153. Date of Electronic Publication: 2021 Oct 28.
Autor:
Simeoni F; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4GJ, UK., Romero-Camarero I; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4GJ, UK., Camera F; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4GJ, UK., Amaral FMR; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4GJ, UK., Sinclair OJ; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4GJ, UK., Papachristou EK; Cancer Research UK Cambridge Institute, Cambridge CB2 0RE, UK., Spencer GJ; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4GJ, UK., Lie-A-Ling M; Stem Cell Biology Group, Cancer Research UK Manchester Institute, The University of Manchester, Macclesfield SK10 4TG, UK., Lacaud G; Stem Cell Biology Group, Cancer Research UK Manchester Institute, The University of Manchester, Macclesfield SK10 4TG, UK., Wiseman DH; Epigenetics of Haematopoiesis Group, Oglesby Cancer Research Building, The University of Manchester, Manchester M20 4GJ, UK., Carroll JS; Cancer Research UK Cambridge Institute, Cambridge CB2 0RE, UK., Somervaille TCP; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4GJ, UK. Electronic address: tim.somervaille@cruk.manchester.ac.uk.
Publikováno v:
Cell reports [Cell Rep] 2021 Sep 21; Vol. 36 (12), pp. 109725.